New grad roles at Definium Therapeutics
Definium Therapeutics is a late-stage clinical biopharmaceutical company developing psychedelic medicines for brain health disorders. Its lead candidate, DT120, is a lysergide tartrate formulation in Phase 3 studies for generalized anxiety disorder and major depressive disorder.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 51–200 employees
- Stage
- Public
- Open roles
- 12
No current roles
Check back soon.
Get new Definium Therapeutics new grad roles by email
Free account. Get new Definium Therapeutics new grad roles by email or push the minute they post.
